Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats.
about
Promising Therapy Candidates for Liver FibrosisHepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next StepNew Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical TrialsEpithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compoundsEndothelial dysfunction in cirrhosis: Role of inflammation and oxidative stressTyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis?PDGFRα in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancerPrevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesThe hepatic apelin system: a new therapeutic target for liver diseaseBevacizumab attenuates hepatic fibrosis in rats by inhibiting activation of hepatic stellate cellsAn ex vivo model for anti-angiogenic drug testing on intact microvascular networksSystems level analysis and identification of pathways and networks associated with liver fibrosisMechanisms of hepatic fibrogenesisComplementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis.Current status of novel antifibrotic therapies in patients with chronic liver diseasePlatelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function.Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in mice.Aquaporin-1 facilitates angiogenic invasion in the pathological neovasculature that accompanies cirrhosisEvolving therapies for liver fibrosis.CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis.Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.Reversible decrease of portal venous flow in cirrhotic patients: a positive side effect of sorafenib.Hepatic fibrosis.Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats.Aquaporin-1 promotes angiogenesis, fibrosis, and portal hypertension through mechanisms dependent on osmotically sensitive microRNAsImmortalized liver endothelial cells: a cell culture model for studies of motility and angiogenesis.Intracellular calcium signals regulate growth of hepatic stellate cells via specific effects on cell cycle progressionLinifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial.Angiopoietin-2 Serum Levels Improve Noninvasive Fibrosis Staging in Chronic Hepatitis C: A Fibrogenic-Angiogenic Link.Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesisVascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.The effect of antifibrotic drugs in rat precision-cut fibrotic liver slices.Intra and extravascular transmembrane signalling of angiopoietin-1-Tie2 receptor in health and disease.Intestinal and plasma VEGF levels in cirrhosis: the role of portal pressure.Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model.Yiguanjian decoction and its ingredients inhibit angiogenesis in carbon tetrachloride-induced cirrhosis mice.Rapamycin Attenuates Splenomegaly in both Intrahepatic and Prehepatic Portal Hypertensive Rats by Blocking mTOR Signaling Pathway.The chinese herbal decoction danggui buxue tang inhibits angiogenesis in a rat model of liver fibrosis.Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitmentSorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation
P2860
Q26766727-5640B235-3B90-476C-9529-77FCBE4644EAQ26771518-4F8D9B3E-068E-406C-8CEB-6F4FF7F36571Q26772800-323D84DC-556D-4856-9902-D001CC631B0CQ27013565-F25E6016-FF33-40DD-8543-D6422E323846Q27023122-7653BCBC-1665-4E75-A1D3-68EE3DF4192AQ28068710-B4F0F053-C1DC-4F89-B87A-4B35BF763B29Q28085644-8C7F4037-D5CC-413C-B671-203703EAA575Q28272678-CAE7DEE0-DC87-4862-BE6A-E8872AA5437DQ28295197-F7EE790A-3769-4150-8E86-94FEA3D2A8CFQ28536257-96B4AAC0-203B-48D1-A802-9C87C61D6368Q28543862-56C8431B-1AE5-4E14-9FA7-3C9E9D78D566Q28544814-9DAC549F-5B51-4F27-B672-2C5B7A6D4ADCQ29619336-4AF23CD0-7995-4D17-9420-5A81FF57409AQ30465168-16F58B45-6FE3-4810-B936-2DC7662577E5Q30473375-2B5F248D-596A-4BD2-8DD2-0FBA31F70B25Q30485959-DF808C2E-A4D3-4E87-82AE-6C235ECFC879Q30493887-69361A24-8377-449F-B73F-48B6B771F295Q30496270-AF885C53-2E49-4F34-9E7F-99AB4DB2124CQ30539166-7D59649B-05E9-46B9-A983-8BAC2E3082AEQ30596736-A5E999ED-7E9E-405E-BCF7-39F8847A7776Q33682848-37419819-A99D-4AB0-B0F0-2F7C9EF4FF53Q33826258-6B4CAF64-ADDC-4E75-9D93-24F5D7C1A943Q33904174-0ED68E40-A29A-4DD3-ADF1-D5AF74A02821Q33920996-9CCC339C-7B0A-4B59-8020-72A22ADC6AF9Q34209321-C95FFFE3-2CA6-42A7-9189-3FE9ACE09980Q34354070-AC49FFB0-04D0-4BDF-9DCE-666B5DFEB564Q34478660-6229028F-893E-410E-84F7-206927186C28Q34786090-093B1AE2-2D09-4B1D-9E70-69801618BBB4Q34792158-009C1EEA-997B-477A-A4C4-C57BD777D0D6Q34902424-06FB4E33-474B-41CC-8FA3-3E92F9C8500BQ35136411-7952AA5B-56C0-4B4D-B361-8A689CFFB2B9Q35154961-C153C343-AAC4-4A22-AEDD-4189C99A65C2Q35458362-9D5C6B28-AB8E-40E1-A5A2-4A3331F0EED4Q35541817-B7B08FF3-7ECB-4359-BC59-27E456E347B7Q35626914-2EC4F7DD-358E-4CE3-8B71-3E3D1C984E90Q35795593-EC320DB1-53D9-4B59-97D3-E9DADF5BE2C7Q35886555-AFDBA072-5767-4EAB-89F3-FBDD308C1ED4Q36180467-00731C3E-2F4B-4209-9EDA-FAEAB9EE6BAAQ36962774-E5BB2D11-BAD6-43C4-A7E1-8728E1C3240AQ36973713-652D3C36-A177-4A2F-A9E1-92192ADB2B79
P2860
Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Antiangiogenic treatment with ...... al pressure in cirrhotic rats.
@en
type
label
Antiangiogenic treatment with ...... al pressure in cirrhotic rats.
@en
prefLabel
Antiangiogenic treatment with ...... al pressure in cirrhotic rats.
@en
P2093
P2860
P50
P356
P1433
P1476
Antiangiogenic treatment with ...... tal pressure in cirrhotic rats
@en
P2093
Guillermo Fernandez-Varo
Javier Muñoz-Luque
Josefa Ros
Juan Rodés
Peter Carmeliet
Scott L Friedman
Sònia Tugues
P2860
P304
P356
10.1002/HEP.21921
P407
P577
2007-12-01T00:00:00Z